Published in Immunology on February 01, 2006
An inducible model of abacterial prostatitis induces antigen specific inflammatory and proliferative changes in the murine prostate. Prostate (2011) 1.68
Rapid tolerization of virus-activated tumor-specific CD8+ T cells in prostate tumors of TRAMP mice. Proc Natl Acad Sci U S A (2008) 1.60
Tumor recognition and self-recognition induce distinct transcriptional profiles in antigen-specific CD4 T cells. J Immunol (2009) 1.07
Combined targeting of costimulatory (OX40) and coinhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust antitumor immunity. Cancer Immunol Res (2013) 1.03
Ligation of the OX40 co-stimulatory receptor reverses self-Ag and tumor-induced CD8 T-cell anergy in vivo. Eur J Immunol (2009) 1.03
Urinary bladder epithelium antigen induces CD8+ T cell tolerance, activation, and autoimmune response. J Immunol (2007) 0.92
Dual anti-OX40/IL-2 therapy augments tumor immunotherapy via IL-2R-mediated regulation of OX40 expression. PLoS One (2012) 0.88
Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T-cell anergy and promotes survival in tumor-bearing mice. Proc Natl Acad Sci U S A (2016) 0.85
Characterization of autoimmune inflammation induced prostate stem cell expansion. Prostate (2015) 0.81
How do I steer this thing? Using dendritic cell targeted vaccination to more effectively guide the antitumor immune response with combination immunotherapy. J Immunother Cancer (2016) 0.77
Immunotherapy Expands and Maintains the Function of High-Affinity Tumor-Infiltrating CD8 T Cells In Situ. J Immunol (2016) 0.75
T cell tolerance to the skin: a central role for central tolerance. Semin Immunopathol (2007) 0.75
Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med (2001) 9.70
CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol (1998) 7.31
Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med (1997) 5.72
Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med (1996) 5.21
Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med (2001) 4.78
Dynamic programming of CD8+ T lymphocyte responses. Nat Immunol (2003) 3.73
A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo. Endocrinology (2000) 2.69
Phenotypic and functional analysis of CD8(+) T cells undergoing peripheral deletion in response to cross-presentation of self-antigen. J Exp Med (2001) 2.49
Self antigens expressed by solid tumors Do not efficiently stimulate naive or activated T cells: implications for immunotherapy. J Exp Med (1997) 2.47
Activation of low avidity CTL specific for a self epitope results in tumor rejection but not autoimmunity. J Immunol (1998) 2.10
Peripheral deletion of autoreactive CD8 T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by Bim. J Exp Med (2002) 1.89
Antigen concentration and precursor frequency determine the rate of CD8+ T cell tolerance to peripherally expressed antigens. J Immunol (1999) 1.86
Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells. Eur J Immunol (1992) 1.83
Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans. Blood (2002) 1.79
Expression of intestine-specific antigen reveals novel pathways of CD8 T cell tolerance induction. Immunity (2000) 1.67
CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose. Proc Natl Acad Sci U S A (1999) 1.55
CD8(+) T cell tolerance to a tumor-associated antigen is maintained at the level of expansion rather than effector function. J Exp Med (2002) 1.53
The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1). J Exp Med (1998) 1.47
Role of antigen-presenting cells in mediating tolerance and autoimmunity. J Exp Med (2000) 1.46
Levels of peripheral T cell tolerance induced by different doses of tolerogen. Science (1994) 1.44
Uncoupling of proliferative potential and gain of effector function by CD8(+) T cells responding to self-antigens. J Exp Med (2002) 1.44
Distinct mechanisms of extrathymic T cell tolerance due to differential expression of self antigen. Int Immunol (1992) 1.32
Inhibition of insulitis and prevention of diabetes in nonobese diabetic mice by blocking L-selectin and very late antigen 4 adhesion receptors. Proc Natl Acad Sci U S A (1993) 1.29
Persistence of physiological self antigen is required for the regulation of self tolerance. J Immunol (2000) 1.19
Memory CD8(+) T cells undergo peripheral tolerance. Immunity (2002) 1.16
Induction of peripheral CD8+ T-cell tolerance by cross-presentation of self antigens. Immunol Rev (1998) 1.10
Deletion of naive CD8 T cells requires persistent antigen and is not programmed by an initial signal from the tolerogenic APC. J Immunol (2003) 1.06
Cutting edge: restoration of the ability to generate CTL in mice immune to adenovirus by delivery of virus in a collagen-based matrix. J Immunol (2001) 1.00
Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152). J Immunol (2000) 0.96
Peptide-induced deletion of CD8 T cells in vivo occurs via apoptosis in situ. Int Immunol (1997) 0.87
Long life span of tolerant T cells and the role of antigen in maintenance of peripheral tolerance. Int Immunol (1995) 0.86
Altered functional and biochemical response by CD8+ T cells that remain after tolerance. Int Immunol (2001) 0.80
Loss of antiviral cytotoxic T-lymphocyte activity during high-level antigen stimulation. Viral Immunol (1998) 0.79
Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell (2003) 6.38
The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes. Mol Endocrinol (2003) 3.01
Laboratory, reading center, and coordinating center data management methods in the Jackson Heart Study. Am J Med Sci (2004) 2.47
Next-generation mapping of Arabidopsis genes. Plant J (2011) 2.39
Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005. Cancer (2009) 2.13
Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity (2003) 1.84
Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles. Blood (2008) 1.83
Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans. Vaccine (2005) 1.79
Diurnal cortisol variations and symptoms in patients with interstitial cystitis. J Urol (2002) 1.73
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun (2013) 1.73
An inducible model of abacterial prostatitis induces antigen specific inflammatory and proliferative changes in the murine prostate. Prostate (2011) 1.68
Cholesterol sulfate imaging in human prostate cancer tissue by desorption electrospray ionization mass spectrometry. Anal Chem (2010) 1.48
Platelet-derived CD154 enables T-cell priming and protection against Listeria monocytogenes challenge. Blood (2008) 1.40
In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site. Eur J Immunol (2011) 1.37
Defects in the acquisition of CD8 T cell effector function after priming with tumor or soluble antigen can be overcome by the addition of an OX40 agonist. J Immunol (2007) 1.24
Accumulation of foxp3+ T regulatory cells in draining lymph nodes correlates with disease progression and immune suppression in colorectal cancer patients. Clin Cancer Res (2010) 1.22
Function and evolution of a MicroRNA that regulates a Ca2+-ATPase and triggers the formation of phased small interfering RNAs in tomato reproductive growth. Plant Cell (2011) 1.20
The emerging role of platelets in adaptive immunity. Cell Immunol (2006) 1.19
Simvastatin and atorvastatin improve neurological outcome after experimental intracerebral hemorrhage. Stroke (2009) 1.18
Prostate inflammation and its potential impact on prostate cancer: a current review. J Cell Biochem (2008) 1.14
A split-path schema-based RFID data storage model in supply chain management. Sensors (Basel) (2013) 1.13
Polo-like kinase 1 facilitates loss of Pten tumor suppressor-induced prostate cancer formation. J Biol Chem (2011) 1.12
Percutaneous vertebroplasty versus balloon kyphoplasty for treatment of osteoporotic vertebral compression fracture: a meta-analysis of randomised and non-randomised controlled trials. Int Orthop (2011) 1.11
Coupled analysis of gene expression and chromosomal location. Genomics (2005) 1.10
Fat dogs and coughing horses: K-12 programming for veterinary workforce development. J Vet Med Educ (2013) 1.08
Poorly-differentiated endocrine carcinomas of midgut and hindgut origin. Neuroendocrinology (2007) 1.06
Role of FcRgamma and factor XIIIA in coated platelet formation. Blood (2005) 1.02
PATE gene clusters code for multiple, secreted TFP/Ly-6/uPAR proteins that are expressed in reproductive and neuron-rich tissues and possess neuromodulatory activity. J Biol Chem (2008) 1.02
Plk1 phosphorylation of orc2 and hbo1 contributes to gemcitabine resistance in pancreatic cancer. Mol Cancer Ther (2012) 1.02
Extensive remodeling of the Pseudomonas syringae pv. avellanae type III secretome associated with two independent host shifts onto hazelnut. BMC Microbiol (2012) 1.02
Phase I clinical trial of an adenovirus/prostate-specific antigen vaccine for prostate cancer: safety and immunologic results. Clin Cancer Res (2009) 1.01
Slow disease progression in a C57BL/6 pten-deficient mouse model of prostate cancer. Am J Pathol (2011) 1.01
T-cell recognition of a prostate specific antigen is not sufficient to induce prostate tissue destruction. Prostate (2006) 1.00
Quantitative CT measures of emphysema and airway wall thickness are related to D(L)CO. Respir Med (2010) 0.99
Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life. Cell Host Microbe (2015) 0.99
Protection of chickens against avian influenza with non-replicating adenovirus-vectored vaccine. Vaccine (2008) 0.99
Inconsistent protective efficacy and marked polymorphism limits the value of Schistosoma japonicum tetraspanin-2 as a vaccine target. PLoS Negl Trop Dis (2011) 0.98
Ovarian cancer risk associated with inherited inflammation-related variants. Cancer Res (2012) 0.98
Nuclear factor of activated T cells (NFAT) mediates CD154 expression in megakaryocytes. Blood (2008) 0.96
Periodontitis and airway obstruction. J Periodontol (2005) 0.95
Ionizing radiation induces neuroendocrine differentiation of prostate cancer cells in vitro, in vivo and in prostate cancer patients. Am J Cancer Res (2011) 0.95
The role of forkhead box A2 to restrict androgen-regulated gene expression of lipocalin 5 in the mouse epididymis. Mol Endocrinol (2006) 0.95
Adenovirus as a carrier for the development of influenza virus-free avian influenza vaccines. Expert Rev Vaccines (2009) 0.92
Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer Epidemiol Biomarkers Prev (2013) 0.92
Cooperation between platelet-derived CD154 and CD4+ T cells for enhanced germinal center formation. J Leukoc Biol (2005) 0.92
SIRT1 inhibits TNF-α-induced apoptosis of vascular adventitial fibroblasts partly through the deacetylation of FoxO1. Apoptosis (2013) 0.91
The role of platelet CD154 in the modulation in adaptive immunity. Immunol Res (2007) 0.90
Androgen-dependent prostate epithelial cell selection by targeting ARR(2)PBneo to the LPB-Tag model of prostate cancer. Lab Invest (2006) 0.90
Antisense treatment against Ki-67 mRNA inhibits proliferation and tumor growth in vitro and in vivo. Int J Cancer (2003) 0.90
Platelet CD40L at the interface of adaptive immunity. Thromb Res (2010) 0.90
Characterization of Sucrose transporter alleles and their association with seed yield-related traits in Brassica napus L. BMC Plant Biol (2011) 0.89
Effect of pH on the Interaction of Gold Nanoparticles with DNA and Application in the Detection of Human p53 Gene Mutation. Nanoscale Res Lett (2008) 0.89
Altered temporal variance and neural synchronization of spontaneous brain activity in anesthesia. Hum Brain Mapp (2014) 0.88
Statins Protect the Blood Brain Barrier Acutely after Experimental Intracerebral Hemorrhage. J Behav Brain Sci (2012) 0.87
α(V)β(6) integrin expression is induced in the POET and Pten(pc-/-) mouse models of prostatic inflammation and prostatic adenocarcinoma. Am J Transl Res (2012) 0.87
The fibronectin attachment protein of bacillus Calmette-Guerin (BCG) mediates antitumor activity. Cancer Immunol Immunother (2007) 0.86
Hepsin cooperates with MYC in the progression of adenocarcinoma in a prostate cancer mouse model. Prostate (2010) 0.86
Selective and shape-selective Baeyer-Villiger oxidations of aromatic aldehydes and cyclic ketones with Sn-beta zeolites and H2O2. Chemistry (2002) 0.85
Cell-intrinsic abrogation of TGF-β signaling delays but does not prevent dysfunction of self/tumor-specific CD8 T cells in a murine model of autochthonous prostate cancer. J Immunol (2012) 0.85
Vascular recovery promoted by atorvastatin and simvastatin after experimental intracerebral hemorrhage: magnetic resonance imaging and histological study. J Neurosurg (2010) 0.85
Rare functioning pancreatic endocrine tumors. Neuroendocrinology (2007) 0.85
Platelet influence on T- and B-cell responses. Arch Immunol Ther Exp (Warsz) (2009) 0.85
Association of rs7903146 (IVS3C/T) and rs290487 (IVS3C/T) polymorphisms in TCF7L2 with type 2 diabetes in 9,619 Han Chinese population. PLoS One (2013) 0.85
Serum metabolomics reveals lipid metabolism variation between coronary artery disease and congestive heart failure: a pilot study. Biomarkers (2013) 0.84
[Four surgical patterns of hysterectomy for uterine without prolapsis: a clinical study]. Zhonghua Yi Xue Za Zhi (2002) 0.84
Label-free DNA sensor by boron-doped diamond electrode using an ac impedimetric approach. Anal Chem (2008) 0.84
PPARα agonist fenofibrate attenuates TNF-α-induced CD40 expression in 3T3-L1 adipocytes via the SIRT1-dependent signaling pathway. Exp Cell Res (2013) 0.84
Systemic and cell-specific immune response to laparoscopic and open nephrectomy in porcine model. J Endourol (2008) 0.84
Early microrecanalization of vas deferens following biodegradable graft implantation in bilaterally vasectomized rats. Asian J Androl (2009) 0.83
Two new cytotoxic pregnane glycosides from Cynanchum auriculatum. Planta Med (2008) 0.82
Induction of protective immunity to RM-1 prostate cancer cells with ALVAC-IL-2/IL-12/TNF-alpha combination therapy. Int J Cancer (2006) 0.82
Association of rs12255372 in the TCF7L2 gene with type 2 diabetes mellitus: a meta-analysis. Braz J Med Biol Res (2013) 0.81
Statins Enhance Expression of Growth Factors and Activate the PI3K/Akt-mediated Signaling Pathway after Experimental Intracerebral Hemorrhage. World J Neurosci (2012) 0.81
The protective effect of fenofibrate against TNF-α-induced CD40 expression through SIRT1-mediated deacetylation of NF-κB in endothelial cells. Inflammation (2014) 0.80
Toward understanding the genetics of regulatory T cells in ovarian cancer. Oncoimmunology (2013) 0.80
DHT inhibits the Aβ25-35-induced apoptosis by regulation of seladin-1, survivin, XIAP, bax, and bcl-xl expression through a rapid PI3-K/Akt signaling in C6 glial cell lines. Neurochem Res (2014) 0.80
Clinical protocol: phase I study of an adenovirus/prostate-specific antigen vaccine in men with metastatic prostate cancer. Hum Gene Ther (2006) 0.80
Spirometry guidelines influence lung function results in a longitudinal study of young adults. Respir Med (2010) 0.79
Facile preparation of lightweight microcellular polyetherimide/graphene composite foams for electromagnetic interference shielding. ACS Appl Mater Interfaces (2013) 0.79
Therapeutic effect of human umbilical tissue-derived cell treatment in rats with experimental intracerebral hemorrhage. Brain Res (2012) 0.79
Urine markers for bladder cancer surveillance: a systematic review. J Urol (2005) 0.78
Expression of TNF-related apoptosis-inducing ligand (TRAIL) in megakaryocytes and platelets. Exp Hematol (2004) 0.78
Acute Statin Treatment Improves Recovery after Experimental Intracerebral Hemorrhage. World J Neurosci (2013) 0.78
Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review). J Urol (2005) 0.78
Immunotherapy of urologic tumors: principles and progress. Urol Oncol (2002) 0.78
Structure/function analysis of the murine CD95L promoter reveals the identification of a novel transcriptional repressor and functional CD28 response element. J Biol Chem (2003) 0.77
Ibuprofen inhibits survival of bladder cancer cells by induced expression of the p75NTR tumor suppressor protein. J Urol (2005) 0.77
Cadmium adsorption by willow root: the role of cell walls and their subfractions. Environ Sci Pollut Res Int (2013) 0.77
Coordinated regulation of arbuscular mycorrhizal fungi and soybean MAPK pathway genes improved mycorrhizal soybean drought tolerance. Mol Plant Microbe Interact (2015) 0.77
Fibronectin attachment protein from bacillus Calmette-Guerin as targeting agent for bladder tumor cells. Int J Cancer (2011) 0.76
Improvement in recovery after experimental intracerebral hemorrhage using a selective cathepsin B and L inhibitor. J Neurosurg (2010) 0.76
Prostate specific antigen detection in patient sera by fluorescence-free BioCD protein array. Biosens Bioelectron (2010) 0.76
Forward chemical genetic screens in Arabidopsis identify genes that influence sensitivity to the phytotoxic compound sulfamethoxazole. BMC Plant Biol (2012) 0.76